CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies

Monash researchers develop model to tackle weight stigma in pregnancy and beyond

People with larger bodies commonly face a pervasive, resilient form of social stigma, often facing discrimination in the workplace as well as in educational and

November 18, 2024

Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 25.07.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

July 26, 2024

Operation Warp Speed but for rare disease

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Today, FDA

June 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.